NLRP3 and neoplasm: Petrilli and colleagues reported an immunosuppressive role of the Nlrp3-Asc-Caspase-1 pathway, that blunted NK cell tumor recruitment and activation, but that was independent of IL-1β, IL-18 or IL-1 receptor signaling.